$PACB News

PacBio to Participate in Upcoming Investor Conferences

Pacific Biosciences of California (PACB) Declines More Than Market: Some Information for Investors

PacBio and Verily Health Announce Multi-Year Strategic Collaboration to Scale Long-Read Genomics for Biomedical AI

PacBio And Verily Health Announce Multi-Year Strategic Collaboration To Integrate PacBio HiFi Sequencing With Verily Health’s Governed Data And AI Platform

Pacific Biosciences of California (PACB) Declines More Than Market: Some Information for Investors

PacBio to Report Third Quarter 2026 Financial Results on November 4, 2026

PacBio (PACB) Stock Gets Fair Value Boost After UBS Starts Coverage Neutral

Why Pacific Biosciences of California (PACB) Dipped More Than Broader Market Today

PacBio Sinks 8% as TychoBio Endorses Its “Highest Quality Biological Data” – the Real Story Is More Complicated

PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics

PacBio, TychoBio Collaborate Over Generation Of RNA Data To Train Models For RNA Therapy Design

Pacific Biosciences of California (PACB) Rises Higher Than Market: Key Facts

Pacific Biosciences: Stock Surges As New Use Case Seen - But Caution Is Warranted

Why PacBio (PACB) Stock Is Trading Up Today

Pacific Biosciences of California (PACB) Beats Stock Market Upswing: What Investors Need to Know

Pacific Biosciences Targets Clinical Growth, $40M Savings With HiFi Sequencing Push

Pacific Biosciences of California, Inc. (PACB) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know

UBS Assumes Pacific Biosciences at Neutral, Lowers Price Target of $1.35

Q2 Earnings Highlights: PacBio (NASDAQ:PACB) Vs The Rest Of The Life Sciences Tools & Services Stocks